Explore an overview of the congresses and events we’re participating in, showcasing our commitment to scientific advancement and innovation.
Upcoming congresses
ACR
November 6 - 11, 2026
Orlando, USA
American College of Rheumatology
ASH
December 12 - 15, 2026
New Orleans, Louisiana
Sobi’s scientific presence grows –
stay tuned
Recent congresses 2026
ASN, 21 - 25 October 2026
Denver, Colorado
American Society of Nephrology
Therapeutic area: Nephrology
UEG, 17 - 20 October 2026
Barcelona, Spain
United European Gastroenterology
Therapeutic area: Metabolic diseases
EHC, 2 - 4 October 2026
Istanbul, Turkey
European Haemophilia Consortium
Disease area: Haemophilia
ESPN, 30 September - 3 October 2026
Bordeaux, France
European Society for Paediatric Nephrology
Therapeutic areas: Nephrology
EASD, 28 September - 2 October 2026
Milan, Italy
European Association for the Study of Diabetes
Therapeutic areas: Metabolic diseases
PReS, 16 - 19 September 2026
Belgrad, Serbien
European Paediatric Rheumatology Society, 2026
Terapiområde: Reumatologi
ESC, 28 - 31 August 2026
Munich, Germany
European Society of Cardiology
Therapeutic area: Metabolic diseases
ISTH, 11 - 15 July 2026
Paris, France
International Society on Thrombosis and Haemostasis
Therapeutic area: Haematology
EHA, 11 - 14 June, 2026
Stockholm, Sweden
European Haematology Association, 2026
Therapeutic area: Haematology
ERA, 3 - 6 June, 2026
Glasgow, Scotland
European Atheroscierosis Society, 2026
Therapeutic area: Nephrology
EULAR, 3 - 6 June, 2026
London, England
European Congress of Rheumatology, 2026
Therapeutic area: Rheumatology
EAS, 24 - 27 May, 2026
Athens, Greece
European Atheroscierosis Society, 2026
Therapeutic area: Metabolic diseases
WFH, 18 - 21 April, 2026
WCN, 28 - 31 March, 2026
EAHAD, 3 - 6 February 2026
Dublin, Ireland
European Association for Haemophilia and Allied Disorders, 2026
Therapeutic area: Haemophilia
Therapeutic areas
Learn more about all our therapeutic areas spanning - Immunology, Haematology, Nephrology and Specialty Care.
Medicines
Read more about our medicines within rare diseases.